Royal Prima PT (PRIM) - Net Assets

Latest as of September 2025: Rp955.60 Billion IDR ≈ $55.99 Million USD

Based on the latest financial reports, Royal Prima PT (PRIM) has net assets worth Rp955.60 Billion IDR (≈ $55.99 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rp1.07 Trillion ≈ $62.51 Million USD) and total liabilities (Rp111.14 Billion ≈ $6.51 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check PRIM cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Rp955.60 Billion
% of Total Assets	89.58%
Annual Growth Rate	N/A
5-Year Change	8.21%
10-Year Change	133030.04%
Growth Volatility	730.84

Royal Prima PT - Net Assets Trend (2014–2024)

This chart illustrates how Royal Prima PT's net assets have evolved over time, based on quarterly financial data. Also explore balance sheet size of Royal Prima PT for the complete picture of this company's asset base.

Annual Net Assets for Royal Prima PT (2014–2024)

The table below shows the annual net assets of Royal Prima PT from 2014 to 2024. For live valuation and market cap data, see PRIM company net worth.

Year	Net Assets	Change
2024-12-31	Rp962.38 Billion ≈ $56.39 Million	-1.91%
2023-12-31	Rp981.10 Billion ≈ $57.49 Million	-0.16%
2022-12-31	Rp982.66 Billion ≈ $57.58 Million	+1.91%
2021-12-31	Rp964.21 Billion ≈ $56.50 Million	+8.42%
2020-12-31	Rp889.35 Billion ≈ $52.11 Million	+4.49%
2019-12-31	Rp851.17 Billion ≈ $49.88 Million	+0.27%
2018-12-31	Rp848.87 Billion ≈ $49.74 Million	+238.97%
2017-12-31	Rp250.42 Billion ≈ $14.67 Million	+1964.88%
2016-12-31	Rp12.13 Billion ≈ $710.64K	+1577.68%
2015-12-31	Rp722.89 Million ≈ $42.36K	+134.36%
2014-12-31	Rp-2.10 Billion ≈ $-123.29K	--

Equity Component Analysis

This analysis shows how different components contribute to Royal Prima PT's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 16511436645000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Retained Earnings	Rp162.81 Billion	16.93%
Common Stock	Rp339.34 Billion	35.30%
Other Comprehensive Income	Rp2.51 Billion	0.26%
Other Components	Rp456.72 Billion	47.51%
Total Equity	Rp961.39 Billion	100.00%

Royal Prima PT Competitors by Market Cap

The table below lists competitors of Royal Prima PT ranked by their market capitalization.

Company	Market Cap
Pineapple Financial Inc. NYSE MKT:PAPL	$16.44 Million
BR.SCH.ED.HLD.SP.ADR CL.A F:BSK0	$16.44 Million
Enzo Biochem Inc NYSE:ENZ	$16.44 Million
Genenta Science SpA ADR NASDAQ:GNTA	$16.45 Million
Tasman Resources Ltd AU:TAS	$16.42 Million
Indbank Merchant Banking Services Limited NSE:INDBANK	$16.42 Million
ViroGates A/S CO:VIRO	$16.41 Million
Maheshwari Logistics Limited NSE:MAHESHWARI	$16.41 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Royal Prima PT's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 980,096,701,000 to 961,386,500,000, a change of -18,710,201,000 (-1.9%).
Net loss of 18,407,912,000 reduced equity.
Other comprehensive income decreased equity by 302,288,000.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	Rp-18.41 Billion	-1.91%
Other Comprehensive Income	Rp-302.29 Million	-0.03%
Other Changes	Rp-1.00K	-0.0%
Total Change	Rp-	-1.91%

Book Value vs Market Value Analysis

This analysis compares Royal Prima PT's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 0.29x
The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2014-12-31	Rp-1052.00	Rp83.00	x
2015-12-31	Rp363.13	Rp83.00	x
2016-12-31	Rp6066.07	Rp83.00	x
2017-12-31	Rp113.76	Rp83.00	x
2018-12-31	Rp293.20	Rp83.00	x
2019-12-31	Rp250.55	Rp83.00	x
2020-12-31	Rp261.82	Rp83.00	x
2021-12-31	Rp283.87	Rp83.00	x
2022-12-31	Rp289.72	Rp83.00	x
2023-12-31	Rp288.82	Rp83.00	x
2024-12-31	Rp284.58	Rp83.00	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Royal Prima PT utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -1.91%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -6.15%
• Asset Turnover: 0.28x
• Equity Multiplier: 1.13x
Recent ROE (-1.91%) is below the historical average (33.57%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2014	0.00%	-13.84%	1.41x	0.00x	Rp-2.09 Billion
2015	251.59%	2.51%	2.68x	37.32x	Rp1.75 Billion
2016	95.16%	8.37%	3.60x	3.15x	Rp10.33 Billion
2017	8.10%	11.37%	0.57x	1.24x	Rp-4.74 Billion
2018	2.03%	8.40%	0.22x	1.08x	Rp-67.57 Billion
2019	0.28%	1.38%	0.19x	1.07x	Rp-82.63 Billion
2020	4.30%	14.65%	0.27x	1.07x	Rp-50.68 Billion
2021	7.83%	12.57%	0.53x	1.17x	Rp-20.88 Billion
2022	2.20%	8.24%	0.25x	1.05x	Rp-76.57 Billion
2023	-0.28%	-1.04%	0.26x	1.05x	Rp-100.76 Billion
2024	-1.91%	-6.15%	0.28x	1.13x	Rp-114.55 Billion

Industry Comparison

This section compares Royal Prima PT's net assets metrics with peer companies in the Medical Care Facilities industry.

Industry Context

Industry: Medical Care Facilities
Average net assets among peers: $3,097,845,277,493
Average return on equity (ROE) among peers: 19.16%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Royal Prima PT (PRIM)	Rp955.60 Billion	0.00%	0.12x	$16.43 Million
Bundamedik Tbk PT (BMHS)	$1.05 Trillion	11.29%	1.06x	$93.26 Million
Metro Healthcare Indonesia (CARE)	$10.62 Billion	98.11%	19.85x	$798.81 Million
Medikaloka Hermina PT (HEAL)	$957.59 Billion	2.02%	0.86x	$1.04 Billion
Lippo Karawaci Tbk (LPKR)	$11.47 Trillion	9.24%	1.17x	$340.56 Million
Mitra Keluarga Karyasehat Tbk PT (MIKA)	$3.64 Trillion	19.12%	0.15x	$1.57 Billion
Kedoya Adyaraya Tbk PT (RSGK)	$798.46 Billion	4.97%	0.11x	$74.90 Million
Sarana Meditama Metropolitan (SAME)	$191.08 Billion	30.39%	1.44x	$333.92 Million
Siloam International Hospitals (SILO)	$8.75 Trillion	10.31%	0.62x	$1.90 Billion
Sejahteraraya Anugrahjaya Tbk (SRAJ)	$1.02 Trillion	-13.02%	0.65x	$10.79 Billion

About Royal Prima PT

JK:PRIM Indonesia Medical Care Facilities

Market Cap

$16.43 Million

Rp280.40 Billion IDR

Market Cap Rank

#25610 Global

#570 in Indonesia

Share Price

Rp83.00

Change (1 day)

-3.49%

52-Week Range

Rp57.00 - Rp102.00

All Time High

Rp1640.00